☆ 4.2 Article

Race, rurality and geographic accessibility to medication for opioid use disorder in the US

JOURNAL OF MAPS (2023)

Related references

Note: Only part of the references are listed.

Article Public, Environmental & Occupational Health

Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior

Penelope Mitchell et al.

Summary: Drug overdose is the leading cause of accidental death in the U.S., with higher rates of opioid overdose in rural areas. The lack of healthcare services exacerbates the opioid crisis, leaving vulnerable populations without access to preventative care, education, harm reduction, and treatment for opioid use disorder (OUD). This study examines the spatial access to medication for OUD in the U.S. and finds extensive 'treatment deserts' with little physical access, particularly in rural areas. The significance of this work lies in the confirmation of gaps in access to OUD services despite federal efforts to improve accessibility.

SOCIAL SCIENCE & MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder

Paul J. Joudrey et al.

Summary: This study found that communities with greater vulnerability did not have better geographic access to medication for opioid use disorder (MOUD), and the mismatch between vulnerability and medication access was greatest in suburban communities. Rural communities had poor geographic access regardless of vulnerability status.

JAMA NETWORK OPEN (2022)

Add to Collection

Editorial Material Psychology, Clinical

A bifurcated opioid treatment system and widening insidious disparities

Erick G. Guerrero et al.

ADDICTIVE BEHAVIORS (2022)

Add to Collection

Article Substance Abuse

County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019

Brian Corry et al.

Summary: This study explores the association between sociodemographic factors and the availability of medications for opioid use disorder (MOUD). The findings show significant differences in the availability of opioid treatment programs (OTPs) and buprenorphine treatment at the county level, with variations related to demographic characteristics, poverty rates, drug overdose death rates, health insurance coverage, and disability rates.

DRUG AND ALCOHOL DEPENDENCE (2022)

Add to Collection

Article Psychology, Clinical

The intersection of race and opioid use disorder treatment: A quantitative analysis*

Rebecca M. Entress

Summary: This study found a relationship between race and treatment for OUD in all three areas examined, with minority groups having a decreased likelihood of being referred to treatment by medical professionals, having MOUD as part of the treatment plan, and leaving treatment because the episode was complete.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Add to Collection

Article Substance Abuse

Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use

Mara A. G. Hollander et al.

Summary: Despite evidence showing that using evidence-based medications for Opioid Use Disorder (MOUD) can lower mortality risk, only 20% of individuals with OUD receive MOUD. Black patients are less likely than White patients to initiate MOUD. Various factors such as criminal justice and human services were measured in relation to MOUD initiation disparities by race, with mediators explaining around one-fifth of the variation in initiation related to race.

DRUG AND ALCOHOL DEPENDENCE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Social and Structural Determinants of Health Inequities in Maternal Health

Joia Crear-Perry et al.

Summary: Social determinants play a crucial role in clinical care and public health, but misuse and lack of context have led to the term losing its meaning. A deeper understanding of social determinants and identifying the forces underlying their distribution is necessary.

JOURNAL OF WOMENS HEALTH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020

Julie O’Donnell et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Substance Abuse

Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017

Megan S. Schuler et al.

Summary: The study found that buprenorphine distribution increased nationally from 2007 to 2017, with disproportionately greater growth in ZIP3s with higher percentages of White residents. Medicaid expansion states showed significant differences in buprenorphine distribution across ZIP3 quintiles during 2007-2010, and the differences increased over time periods. Non-expansion states exhibited significant quintile differences during 2011-2014 and 2015-2017.

DRUG AND ALCOHOL DEPENDENCE (2021)

Add to Collection

Article Substance Abuse

Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US

Gerald J. Stahler et al.

Summary: This study found racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) in short-term residential treatment, with Blacks and Hispanics less likely to receive treatment compared to Whites. Results were mixed for long-term residential treatment, with varying effects of MOUD on treatment completion among different racial/ethnic groups.

DRUG AND ALCOHOL DEPENDENCE (2021)

Add to Collection

Article Psychology, Clinical

Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19

Max Jordan Nguemeni Tiako

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Add to Collection

Article Health Care Sciences & Services

Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine

C. Holly A. Andrilla et al.

JOURNAL OF RURAL HEALTH (2020)

Add to Collection

Article Medicine, General & Internal

Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States

William C. Goedel et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Substance Abuse

Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective

Marynia A. Kolak et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

Add to Collection

Article Social Issues

Race as a Ghost Variable in (White) Opioid Research

Helena Hansen et al.

SCIENCE TECHNOLOGY & HUMAN VALUES (2020)

Add to Collection

Letter Psychiatry

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

Pooja A. Lagisetty et al.

JAMA PSYCHIATRY (2019)

Add to Collection

Article Health Care Sciences & Services

Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment

Hannah K. Knudsen et al.

JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas — United States, 2015–2017

Kumiko M. Lippold et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)

Add to Collection

Article Health Care Sciences & Services

County-level access to opioid use disorder medications in medicare Part D (2010-2015)

Amanda J. Abraham et al.

HEALTH SERVICES RESEARCH (2019)

Add to Collection

Review Public, Environmental & Occupational Health

A scoping review of opioid misuse in the rural United States

Laura C. Palombi et al.

ANNALS OF EPIDEMIOLOGY (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Trends in Black and White Opioid Mortality in the United States, 1979-2015

Monica J. Alexander et al.

EPIDEMIOLOGY (2018)

Add to Collection

Article Ethics

The Opioid Crisis in Black Communities

Keturah James et al.

JOURNAL OF LAW MEDICINE & ETHICS (2018)

Add to Collection

Article History

Treating Addiction or Reducing Crime? Methadone Maintenance and Drug Policy Under the Nixon Administration

Mical Raz

JOURNAL OF POLICY HISTORY (2017)

Add to Collection

Article Substance Abuse

Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City

Helena Hansen et al.

DRUG AND ALCOHOL DEPENDENCE (2016)

Add to Collection

Article Substance Abuse

Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis

Bobbi Jo H. Yarborough et al.

DRUG AND ALCOHOL DEPENDENCE (2016)

Add to Collection

Article Immunology

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States

Michelle M. Van Handel et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)

Add to Collection

Editorial Material Substance Abuse

Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders

Miriam Komaromy et al.

SUBSTANCE ABUSE (2016)

Add to Collection

Article Anthropology

The War on Drugs That Wasn't: Wasted Whiteness, Dirty Doctors, and Race in Media Coverage of Prescription Opioid Misuse

Julie Netherland et al.

CULTURE MEDICINE AND PSYCHIATRY (2016)

Add to Collection

Article Public, Environmental & Occupational Health

Structural competency: Theorizing a new medical engagement with stigma and inequality

Jonathan M. Metzl et al.

SOCIAL SCIENCE & MEDICINE (2014)

Add to Collection

Article Public, Environmental & Occupational Health

Distance Traveled and Cross-State Commuting to Opioid Treatment Programs in the United States

Andrew Rosenblum et al.

JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH (2011)

Add to Collection

Article Medicine, General & Internal

Factors associated with the health care utilization of homeless persons

MB Kushel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)

Add to Collection

Article Medicine, General & Internal

Drug dependence, a chronic medical illness - Implications for treatment, insurance, and outcomes evaluation

AT McLellan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.